Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 279

Results For "CRO"

4634 News Found

IOL Chemicals and Pharmaceuticals Q3 FY23 income down 6%
News | February 09, 2023

IOL Chemicals and Pharmaceuticals Q3 FY23 income down 6%

The company completed paracetamol capacity expansion by 1,800 MTPA and the company is now focusing on frugal manufacturing practices to reduce raw material cost and expand margins


Alembic Pharmaceuticals Q3 FY23 revenue up 19% to Rs. 1,509 Cr
News | February 07, 2023

Alembic Pharmaceuticals Q3 FY23 revenue up 19% to Rs. 1,509 Cr

Net sales for 9M FY23 up 9% to Rs. 4,246 crore and net profit for 9M FY23 at Rs. 189 crore


Bal Pharma posts Q3 FY2023 profit at Rs. 59.16 lakhs
News | February 07, 2023

Bal Pharma posts Q3 FY2023 profit at Rs. 59.16 lakhs

The company has reported total income of Rs.77.0791 crores during the period ended December 31, 2022 as compared to Rs.69.9191 crores during the period ended December 31, 2021.


Need a paradigm shift for popularising ayurveda in India
News | February 07, 2023

Need a paradigm shift for popularising ayurveda in India

For discovery or for standardization, Ayurveda colleges/institutes need to collaborate closely with Phytochemists, Pharmacologists, and Toxicologists from premier institutions


ART and Surrogacy Bill strives to provide patients with better medical care and security: Dr. Mandaviya
News | February 06, 2023

ART and Surrogacy Bill strives to provide patients with better medical care and security: Dr. Mandaviya

With the on-going relentless efforts to imbibe new developments in ART, India will make significant progress in ensuring the best facilities and care for fertility to couples in India


Janssen and Eli Lilly collaboration to address lack of pediatric therapies could rescue mirikizumab program, says GlobalData
News | February 06, 2023

Janssen and Eli Lilly collaboration to address lack of pediatric therapies could rescue mirikizumab program, says GlobalData

The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).


Krsnaa Diagnostics completes Tripura project
News | February 04, 2023

Krsnaa Diagnostics completes Tripura project

Company has provided Image Transmission and Reporting of Radiology Images and Selective Radiology Services (X-ray Tele Radiology Services) across all districts in the state of Tripura during the month of June, 2022 and operationalized its services at all the allocated places as on date.


GMM Pfaudler posts Q3 FY23 consolidated profit at Rs. 18.67 Cr
News | February 03, 2023

GMM Pfaudler posts Q3 FY23 consolidated profit at Rs. 18.67 Cr

The company has reported total income of Rs. 781.40 crores during the period ended December 31, 2022


Theramex select CARA Life Sciences Platform to consolidate and digitise Regulatory Processes
Digitisation | February 03, 2023

Theramex select CARA Life Sciences Platform to consolidate and digitise Regulatory Processes

Theramex were searching for a platform to digitise the manual processes across their R&D landscape


Dabur India consolidated Q3FY23 PAT lower at Rs. 475.94 Cr
News | February 03, 2023

Dabur India consolidated Q3FY23 PAT lower at Rs. 475.94 Cr

The company has posted net profit of Rs. 475.94 crores for the period ended December 31, 2022